Literature DB >> 2807531

Macrophage-activating T-cell factor(s) produced in an early phase of Legionella pneumophila infection in guinea pigs.

Y Nikaido1, S Yoshida, Y Goto, Y Mizuguchi, A Kuroiwa.   

Abstract

Protective immunity of guinea pigs against Legionella pneumophila was studied by infecting the animals with a sublethal dose (about 2 x 10(4) CFU) of the organism. The bacteria multiplied in the liver, spleen, and lungs up to day 4 after the intraperitoneal infection. The live bacteria in these organs decreased quickly thereafter and were eliminated by day 7. A delayed-type skin reaction and lymphoproliferation of spleen cells to Formalin-killed L. pneumophila were detected from days 5 and 6, respectively, after infection. Peritoneal macrophages obtained from guinea pigs infected 6 days previously inhibited the intracellular growth of L. pneumophila. Antigen-stimulated spleen cell factor prepared from infected guinea pigs inhibited the intracellular growth of the organism in macrophages obtained from uninfected animals. Antigen-stimulated spleen cell factor prepared from spleen cells treated with anti-guinea pig T-cell monoclonal antibody did not inhibit growth. The activity of antigen-stimulated spleen cell factor was labile to pH 2 treatment, and the factor could not be absorbed by L. pneumophila antigen, suggesting that it contains gamma interferon. Our data show that T-cell-mediated immunity begins to work from an early period of infection with L. pneumophila in guinea pigs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2807531      PMCID: PMC259853          DOI: 10.1128/iai.57.11.3458-3465.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Dissociation between delayed-type hypersensitivity and resistance to pathogenic mycobacteria demonstrated by T-cell clones.

Authors:  S Hussein; J Curtis; H Akuffo; J L Turk
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

2.  Direct activation of human monocyte-derived macrophages by a bacterial glycoprotein extract inhibits the intracellular multiplication of virulent Legionella pneumophila serogroup 1.

Authors:  P Rajagopalan; E Dournon; J L Vildé; J J Pocidalo
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

3.  Immunological memory in tuberculosis. I. Influence of persisting viable organisms.

Authors:  M J Lefford; D D McGregor
Journal:  Cell Immunol       Date:  1974-12       Impact factor: 4.868

4.  Fate of Legionella pneumophila Philadelphia-1 strain in resident, elicited, activated, and immune peritoneal macrophages of guinea pigs.

Authors:  S Yoshida; Y Mizuguchi; Y Nikaido; M Mitsuyama; K Nomoto
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

5.  IFN-gamma-activated human alveolar macrophages inhibit the intracellular multiplication of Legionella pneumophila.

Authors:  T W Nash; D M Libby; M A Horwitz
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

6.  Pathogenicity of Mycobacterium avium for human monocytes: absence of macrophage-activating factor activity of gamma interferon.

Authors:  H Toba; J T Crawford; J J Ellner
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

7.  Multiplication of Legionella pneumophila Philadelphia-1 in cultured peritoneal macrophages and its correlation to susceptibility of animals.

Authors:  S Yoshida; Y Mizuguchi
Journal:  Can J Microbiol       Date:  1986-05       Impact factor: 2.419

8.  Relation between delayed skin reactivity and macrophage migration inhibition or lymphocyte transformation in tuberculin-type hypersensitivity and Jones-Mote hypersensitivity.

Authors:  K Himeno; K Nomoto; A Kuroiwa; S Miyazaki; K Takeya
Journal:  Microbiol Immunol       Date:  1977       Impact factor: 1.955

9.  The influence of immunologically committed lymphoid cells on macrophage activity in vivo.

Authors:  G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

10.  Guinea pigs sublethally infected with aerosolized Legionella pneumophila develop humoral and cell-mediated immune responses and are protected against lethal aerosol challenge. A model for studying host defense against lung infections caused by intracellular pathogens.

Authors:  R F Breiman; M A Horwitz
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

View more
  4 in total

1.  Legionella pneumophila htpAB heat shock operon: nucleotide sequence and expression of the 60-kilodalton antigen in L. pneumophila-infected HeLa cells.

Authors:  P S Hoffman; L Houston; C A Butler
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

2.  Genetic control of natural resistance in mouse macrophages regulating intracellular Legionella pneumophila multiplication in vitro.

Authors:  S Yoshida; Y Goto; Y Mizuguchi; K Nomoto; E Skamene
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

3.  Interferon-gamma (IFN-gamma) production by human T lymphocytes upon Legionella pneumophila stimulation in vitro.

Authors:  K Kitsukawa; A Nakamoto; H Koito; Y Matsuda; A Saito; H Yamamoto
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

Review 4.  The guinea pig as a model of infectious diseases.

Authors:  Danielle J Padilla-Carlin; David N McMurray; Anthony J Hickey
Journal:  Comp Med       Date:  2008-08       Impact factor: 0.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.